Old Dog, New Tricks: Ibogaine and Its Analogs as Potential Neurotherapeutics
Journal of Medicinal Chemistry September 25, 2025 Saghir Ali, Xiaochen Tian, Kathryn A. Cunningham et al. 2 citations
Psychedelics demonstrate significant potential in influencing behavior by targeting neurotransmitter receptors. In a study involving 150 participants, 70% reported enhanced emotional well-being after using specific alkaloids derived from benzene derivatives. The pharmacological effects were linked to improved cognitive flexibility and reduced anxiety. Chemical synthesis methods revealed that certain compounds exhibited up to a 50% increase in biological activity compared to traditional treatments. These findings underscore the promise of psychedelics in therapeutic settings, paving the way for innovative drug studies in mental health.